National Diabetes Awareness Month 2019

Diabetes Related Technology Available For License

CU Innovations is committed to improving the lives of people around the world by delivering breakthrough cures to patients. CU Innovations helps to further the development of biomedical technology by providing tech transfer support for the University of Colorado Anschutz Medical Campus. View a few of our diabetes related technologies available for license below. Consult with us if you have interest or questions in one of our technologies.

dna cell lines

Mouse cell lines for insulin research

dna cell lines

Research tool for Type 1 diabetes antigen discovery studies

drug target

Treatment for metabolic syndrome and obesity-related conditions such as diabetes


Drug that lowers blood urate levels useful for treating diabetes

MicroRNAs for diagnosing and treating diabetes


Test for Type 1a Diabetes

vaccine and injection

Vaccine to inhibit Type-1 diabetes and other autoimmune diseases

drug delivery

Device to monitor blood glucose and administer insulin delivery

mouse model

Mouse model for testing drugs for Type 1 Diabetes


Cell diagnostic tool for monitoring the development and progression of Type 1 Diabetes

dna piece

Gene manipulation tool to advance the study of diabetes

dna cell lines

Research tool for the study of pathways linked to diabetes and heart failure

CU Innovations

CU Anschutz

Anschutz Health Sciences Building

1890 N Revere Ct

Suite 6202

Mail Stop F411

Aurora, CO 80045


CMS Login